Stock Information
Indivior PLC (INDV)
Ticker Symbol: INDV
Exchange: NASDAQ
Sector: N/A
Market Cap: $4,337.42 mil
Piotroski score: 6
PE Ratio: 33.5907
EPS (TTM): 0.9833
Revenue (TTM): $9.15 M
Dividend Yield: N/A%
ROE: 159.06%
Latest News
-
Indivior Pharmaceuticals Inc (NASDAQ:INDV) Surpasses Q4 2025 Estimates and Provides Strong 2026 Outlook
Thu, Feb 26, 2026 1:24 PM
-
Insights into Indivior Pharmaceuticals Q4 Earnings
Thu, Feb 26, 2026 8:02 AM
-
Indivior Pharmaceuticals Affirms FY2026 Sales Guidance of $1.125B-$1.195B
Thu, Feb 26, 2026 8:01 AM
-
Indivior Q4 Adj. EPS $0.82 Beats $0.67 Estimate, Sales $358.000M Beat $305.620M Estimate
Thu, Feb 26, 2026 8:01 AM
-
Earnings Scheduled For February 26, 2026
Thu, Feb 26, 2026 7:11 AM
-
INDIVIOR PHARMACEUTICALS INC (NASDAQ:INDV) Presents a High-Growth Momentum and Technical Setup Case
Fri, Feb 20, 2026 1:50 PM
-
Indivior Pharmaceuticals to Report Q4 Earnings: What's in the Cards?
Thu, Feb 19, 2026 2:45 PM
Key Financials
Financial data not available
